Sarepta Therapeutics SRPT
Last Price
52 Week Range
$10.41 - $111.20
Next Earnings Date
Feb 25 2026
Next Earnings Date
Feb 25 2026
Last Price
SRPT Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Sarepta Therapeutics, Inc. | HR 13F | February 13, 2026 | |
Sarepta Therapeutics, Inc. | 8-K | January 12, 2026 | |
Sarepta Therapeutics, Inc. | 8-K | December 19, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | December 11, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | December 8, 2025 | |
Sarepta Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | November 3, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | August 29, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | August 21, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | August 13, 2025 | |
Sarepta Therapeutics, Inc. | 10-Q | August 6, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | July 21, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | July 16, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | June 6, 2025 | |
Sarepta Therapeutics, Inc. | 10-Q | May 6, 2025 | |
Sarepta Therapeutics, Inc. | DEFA14A | April 24, 2025 | |
Sarepta Therapeutics, Inc. | ARS | April 24, 2025 | |
Sarepta Therapeutics, Inc. | DEF 14A | April 24, 2025 | |
Sarepta Therapeutics, Inc. | S3ASR | March 3, 2025 | |
Sarepta Therapeutics, Inc. | 10-K | February 28, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | February 26, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | February 14, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | January 13, 2025 | |
Sarepta Therapeutics, Inc. | 8-K | November 26, 2024 | |
Sarepta Therapeutics, Inc. | 10-Q | November 6, 2024 | |
Sarepta Therapeutics, Inc. | 8-K | September 16, 2024 | |
Sarepta Therapeutics, Inc. | 10-Q | August 7, 2024 | |
Sarepta Therapeutics, Inc. | 8-K | June 7, 2024 | |
Sarepta Therapeutics, Inc. | 10-Q | May 1, 2024 | |
Sarepta Therapeutics, Inc. | DEF 14A | April 24, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.